1. Home
  2. PLRX vs IMXI Comparison

PLRX vs IMXI Comparison

Compare PLRX & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • IMXI
  • Stock Information
  • Founded
  • PLRX 2015
  • IMXI 1994
  • Country
  • PLRX United States
  • IMXI United States
  • Employees
  • PLRX N/A
  • IMXI N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • PLRX Health Care
  • IMXI Technology
  • Exchange
  • PLRX Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • PLRX 680.3M
  • IMXI 619.2M
  • IPO Year
  • PLRX 2020
  • IMXI N/A
  • Fundamental
  • Price
  • PLRX $11.77
  • IMXI $19.21
  • Analyst Decision
  • PLRX Strong Buy
  • IMXI Buy
  • Analyst Count
  • PLRX 7
  • IMXI 6
  • Target Price
  • PLRX $40.50
  • IMXI $27.50
  • AVG Volume (30 Days)
  • PLRX 485.5K
  • IMXI 146.1K
  • Earning Date
  • PLRX 02-26-2025
  • IMXI 02-25-2025
  • Dividend Yield
  • PLRX N/A
  • IMXI N/A
  • EPS Growth
  • PLRX N/A
  • IMXI 21.49
  • EPS
  • PLRX N/A
  • IMXI 1.80
  • Revenue
  • PLRX N/A
  • IMXI $665,673,000.00
  • Revenue This Year
  • PLRX N/A
  • IMXI $2.65
  • Revenue Next Year
  • PLRX N/A
  • IMXI $2.82
  • P/E Ratio
  • PLRX N/A
  • IMXI $10.53
  • Revenue Growth
  • PLRX N/A
  • IMXI 3.79
  • 52 Week Low
  • PLRX $10.22
  • IMXI $16.17
  • 52 Week High
  • PLRX $18.00
  • IMXI $23.28
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 47.63
  • IMXI 35.83
  • Support Level
  • PLRX $10.35
  • IMXI $18.39
  • Resistance Level
  • PLRX $11.07
  • IMXI $19.86
  • Average True Range (ATR)
  • PLRX 0.55
  • IMXI 0.49
  • MACD
  • PLRX 0.11
  • IMXI -0.11
  • Stochastic Oscillator
  • PLRX 55.75
  • IMXI 19.90

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: